icone plus
Contact
Abonnez-vous aux actualités
Reason for request
Inclusion
Clinical Benefit
Substantial
Substantial actual benefit
Clinical Added Value
no clinical added value
EYLEA 40 mg/ml, solution for injection in a prefilled syringe and solution for injection in a vial, does not provide an improvement in actual benefit (IAB V) compared with LUCENTIS 10 mg/ml, solution for injection.
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
5wTuhjhwQ94W5VDC